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Synopsis
VERDICT (Vascular, Extracellular, and Restricted Diﬀusion for Cytometry in Tumours) MRI combines a diﬀusion-weighted MRI acquisition
with a three-compartment mathematical model that describes signal from i) intracellular water (fIC), ii) water in extracellular-extravascular
space (fEES) and iii) water in the microvasculature (fvasc). In contrast to VERDICT, clinical ADC is derived from a mono-exponential model.
Upon comparison between VERDICT parameters and clinical ADC, we showed that fIC was better able to discriminate between Gleason
≥3+4 histology pattern and Gleason ≤3+3/benign histology. We also showed that image quality of VERDICT-MRI maps and clinical ADC was
comparable.
Introduction
Multi-parametric MRI (mpMRI) consists of T2-weighted, diﬀusion-weighted (DW) imaging with apparent diﬀusion coeﬃcient (ADC) map and dynamic
contrast-enhanced imaging (DCE-MRI)(1). VERDICT-MRI (Vascular, Extracellular, and Restricted Diﬀusion for Cytometry in Tumours) is a novel
quantitative microstructural imaging tool for prostate cancer (2). It combines a five-non-zero-b-value DW-MRI acquisition with a three-compartment
mathematical model that describes signal from i) intracellular water (fIC), ii) water in extracellular-extravascular space (fEES) and iii) water in the
microvasculature (fvasc) (3). Clinical ADC is derived from a mono-compartmental model and single non-zero b-value. Clinical ADC conflates
parameters like cell density, size, permeability, subcellular structure and vascular perfusion, which may cancel each other’s eﬀects, while VERDICT
aims to quantify them separately thus enhancing sensitivity and specificity (2). We previously assessed the repeatability of VERDICT parameters and
their correlation to histology (4). The aims of this study are: (a) to compare the accuracy of each VERDICT parameter (fIC, fEES, fvasc), ADC and
early-enhancement T1-weighted DCE-MRI to distinguish between presence of Gleason ≥3+4 and Gleason ≤6/benign histology and (b), compare
image quality of VERDICT parameters and ADC. 
Methods
62 men with suspected prostate cancer or undergoing active surveillance were recruited as part of a prospective trial. They all had a 3T prostate
mpMRI and VERDICT-MRI (protocols shown in Tables 1&2). Thirty-eight men with a focal prostate lesion identified as PI-RADS 3, 4 or 5 (1) underwent
targeted transperineal template biopsy. Figure 1 illustrates a prostate mpMRI and VERDICT-MRI study.
A board-certified radiologist manually contoured a region-of-interest (ROI) for each focal index lesion (i.e the most suspicious lesion) on the ADC map,
DCE-MRI and VERDICT-MRI parametric maps (fIC, fEES, fvasc). Quantitative mean values of ADC, fIC, fEES, fvasc and the mean signal intensity of
early-enhanced DCE-MRI (DCE-MRIEE) were obtained. The reference standard was histology from targeted transperineal template biopsy. The cohort
(n=38) was divided into two groups: Gleason ≥3+4 pattern and Gleason ≤3+3/benign (5). Receiver-operator characteristic curves (ROC) were plotted
and area-under-the-curve (AUC) calculated for each parameter.
To compare image quality of VERDICT maps (fIC, fEES, fvasc) and ADC, two board-certified radiologists and an MRI physicist qualitatively assessed
in consensus each map for the 62 patients. Influence of image artifact on diagnostic quality was scored using a subjective 1-5 ordinal scale (6) where
score 1: very poor quality, non-diagnostic (artifacts on all slices, scans uninterpretable); 2: poor quality with some impairment of diagnostic quality
(substantial artifacts, but still interpretable); 3: satisfactory quality without impairment of diagnostic quality (some artifacts present); 4: good quality
(hardly any artifacts); 5: excellent quality (no artifacts present). The Freidman test with Dunn’s multiple comparison correction was performed to
determine the diﬀerences between overall image quality.
Results
Of the 38 patients with biopsy results, 23 harbored Gleason ≥3+4 pattern. The ROC curves comparing each VERDICT diﬀusion parameter to
discriminate between histology Gleason ≥3+4 and Gleason ≤3+3/benign are shown in Figure 2. The AUC of fIC, fEES, fvasc were 0.777, 0.765 and
0.549 respectively. Those of ADC and DCE-MRIEE were 0.692 and 0.596 respectively. Table 2 summarizes the results for the image quality
assessment of VERDICT parameters and ADC.
Discussion
Our study showed that the intracellular fraction of VERDICT MRI (fIC) had the highest AUC compared to the other VERDICT and clinical mpMRI
parameters in distinguishing between Gleason score ≥3+4 and Gleason score ≤3+3/benign histology. We also showed that the mean score of image
quality is very similar amongst all VERDICT parameters and clinical ADC with no statistical diﬀerence found.
The ability of VERDICT fIC to make the distinction between the presence/absence of Gleason 4 component is of clinical relevance as it may represent
a potential non-invasive biomarker in prostate cancer management including active surveillance to better select patients who could avoid a biopsy. Its
application to clinical use would necessitate validation in clinical studies.
1 1 1 1 2
3 3 3 4 3 3 4
3 4 3 3 3 2
1 2 3
4
The added complexity of the VERDICT model did not contribute to lowering the image quality of the VERDICT maps. Image quality in VERDICT
parametric maps was similar to ADC. This is because the voxel size was the same and so the spatial resolution of these maps was equivalent. Also,
same echo-planar based sequences were used, lending to the same causes of image artifact. The mean scores of ADC image quality in our cohort
(3.16-3.23) were comparable to those published in a previous study (3.03-3.08)(7).
Conclusion
Our study demonstrates that the intracellular fraction of VERDICT MRI (fIC) was most able to distinguish between Gleason score ≥3+4 and Gleason
score ≤3+3/benign histology. We also found that there is no diﬀerence in image quality between each VERDICT parameter and clinical ADC.
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